• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

温度诱导的药物纳米混悬剂表面效应。

Temperature-Induced Surface Effects on Drug Nanosuspensions.

机构信息

Institute of Pharma Technology, University of Applied Sciences Northwest, Switzerland, Gründenstrasse 40, Basel, Switzerland.

Swiss Nanoscience Institute, Nano Imaging Lab, University of Basel, Klingelbergstrasse 82, Basel, Switzerland.

出版信息

Pharm Res. 2018 Feb 21;35(3):69. doi: 10.1007/s11095-017-2300-6.

DOI:10.1007/s11095-017-2300-6
PMID:29468420
Abstract

PURPOSE

The trial-and-error approach is still predominantly used in pharmaceutical development of nanosuspensions. Physicochemical dispersion stability is a primary focus and therefore, various analytical bulk methods are commonly employed. Clearly less attention is directed to surface changes of nanoparticles even though such interface effects can be of pharmaceutical relevance. Such potential effects in drug nanosuspensions were to be studied for temperatures of 25 and 37°C by using complementary surface analytical methods.

METHODS

Atomic force microscopy, inverse gas chromatography and UV surface dissolution imaging were used together for the first time to assess pharmaceutical nanosuspensions that were obtained by wet milling. Fenofibrate and bezafibrate were selected as model drugs in presence of sodium dodecyl sulfate and hydroxypropyl cellulose as anionic and steric stabilizer, respectively.

RESULTS

It was demonstrated that in case of bezafibrate nanosuspension, a surface modification occurred at 37°C compared to 25°C, which notably affected dissolution rate. By contrast, no similar effect was observed in case of fenofibrate nanoparticles.

CONCLUSIONS

The combined usage of analytical surface methods provides the basis for a better understanding of phenomena that take place on drug surfaces. Such understanding is of importance for pharmaceutical development to achieve desirable quality attributes of nanosuspensions.

摘要

目的

在药物纳米混悬剂的开发中,仍然主要采用反复试验的方法。物理化学分散稳定性是主要关注点,因此通常采用各种分析方法。尽管纳米颗粒表面的变化可能具有药物相关性,但人们显然较少关注这些界面效应。本研究采用互补的表面分析方法,研究了 25 和 37°C 温度下药物纳米混悬剂的潜在表面变化。

方法

首次将原子力显微镜、反气相色谱法和 UV 表面溶解成像法结合用于评估通过湿磨获得的药物纳米混悬剂。选择非诺贝特和苯扎贝特作为模型药物,十二烷基硫酸钠和羟丙基纤维素分别作为阴离子和空间位阻稳定剂。

结果

研究表明,与 25°C 相比,37°C 时,贝扎贝特纳米混悬剂的表面发生了修饰,这显著影响了药物的溶出速率。相比之下,非诺贝特纳米颗粒则没有观察到类似的效果。

结论

分析表面方法的联合使用为更好地理解药物表面发生的现象提供了基础。这种理解对于药物开发实现纳米混悬剂所需的质量属性具有重要意义。

相似文献

1
Temperature-Induced Surface Effects on Drug Nanosuspensions.温度诱导的药物纳米混悬剂表面效应。
Pharm Res. 2018 Feb 21;35(3):69. doi: 10.1007/s11095-017-2300-6.
2
Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?纤维素聚合物与阴离子表面活性剂的组合是否是确保BCS II类药物纳米混悬液物理稳定性的良好策略?
Pharm Dev Technol. 2016;21(4):499-510. doi: 10.3109/10837450.2015.1022788. Epub 2015 Mar 16.
3
Formulation and drying of miconazole and itraconazole nanosuspensions.米康唑和伊曲康唑纳米混悬剂的制备和干燥。
Int J Pharm. 2013 Feb 25;443(1-2):209-20. doi: 10.1016/j.ijpharm.2012.11.044. Epub 2013 Jan 4.
4
Study of Rheology and Polymer Adsorption Onto Drug Nanoparticles in Pharmaceutical Suspensions Produced by Nanomilling.纳米研磨制备药物纳米粒混悬剂中流变学和聚合物吸附研究。
J Pharm Sci. 2017 Nov;106(11):3395-3401. doi: 10.1016/j.xphs.2017.07.006. Epub 2017 Jul 18.
5
Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability.咪康唑纳米混悬剂:制剂变量对粒径减小和物理稳定性的影响。
Int J Pharm. 2010 Aug 30;396(1-2):210-8. doi: 10.1016/j.ijpharm.2010.06.020. Epub 2010 Jun 19.
6
Enhanced physical stabilization of fenofibrate nanosuspensions via wet co-milling with a superdisintegrant and an adsorbing polymer.通过与超级崩解剂和吸附性聚合物进行湿共研磨增强非诺贝特纳米混悬液的物理稳定性
Eur J Pharm Biopharm. 2015 Aug;94:372-85. doi: 10.1016/j.ejpb.2015.05.028. Epub 2015 Jun 14.
7
Fast dissolution of poorly water soluble drugs from fluidized bed coated nanocomposites: Impact of carrier size.难溶性药物在流化床包衣纳米复合材料中的快速溶解:载体尺寸的影响。
Int J Pharm. 2016 Nov 20;513(1-2):319-331. doi: 10.1016/j.ijpharm.2016.09.046. Epub 2016 Sep 14.
8
Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.难溶性药物的可再分散速溶纳米复合微粒
Int J Pharm. 2014 Jan 30;461(1-2):367-79. doi: 10.1016/j.ijpharm.2013.11.059. Epub 2013 Dec 11.
9
Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.制备并评价非诺贝特纳米晶的体内外性质。
Int J Pharm. 2013 Oct 15;455(1-2):267-75. doi: 10.1016/j.ijpharm.2013.07.021. Epub 2013 Jul 20.
10
Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.湿磨灰黄霉素纳米混悬剂的多面特性研究,阐明其聚集状态和稳定机制。
AAPS PharmSciTech. 2018 May;19(4):1789-1801. doi: 10.1208/s12249-018-0993-4. Epub 2018 Mar 30.

引用本文的文献

1
Nanosuspension-Based Drug Delivery Systems for Topical Applications.基于纳米混悬剂的经皮给药系统。
Int J Nanomedicine. 2024 Jan 25;19:825-844. doi: 10.2147/IJN.S447429. eCollection 2024.
2
Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy.草药纳米晶体:一种有潜力的新型治疗策略。
Molecules. 2023 Aug 31;28(17):6370. doi: 10.3390/molecules28176370.
3
Predicting the Temperature Evolution during Nanomilling of Drug Suspensions via a Semi-Theoretical Lumped-Parameter Model.通过半理论集总参数模型预测药物悬浮液纳米研磨过程中的温度演变

本文引用的文献

1
Systematic Screening of Different Surface Modifiers for the Production of Physically Stable Nanosuspensions.用于制备物理稳定纳米混悬液的不同表面修饰剂的系统筛选
J Pharm Sci. 2015 Mar;104(3):1128-1140. doi: 10.1002/jps.24266. Epub 2016 Jan 8.
2
Study of Rheology and Polymer Adsorption Onto Drug Nanoparticles in Pharmaceutical Suspensions Produced by Nanomilling.纳米研磨制备药物纳米粒混悬剂中流变学和聚合物吸附研究。
J Pharm Sci. 2017 Nov;106(11):3395-3401. doi: 10.1016/j.xphs.2017.07.006. Epub 2017 Jul 18.
3
A recent trend of drug-nanoparticles in suspension for the application in drug delivery.
Pharmaceutics. 2022 Dec 18;14(12):2840. doi: 10.3390/pharmaceutics14122840.
4
An Enthalpy-Balance Model for Timewise Evolution of Temperature during Wet Stirred Media Milling of Drug Suspensions.药物混悬液湿搅拌介质研磨过程中温度随时间演变的焓平衡模型。
Pharm Res. 2022 Sep;39(9):2065-2082. doi: 10.1007/s11095-022-03346-3. Epub 2022 Aug 2.
药物纳米颗粒悬浮液在药物递送应用中的最新趋势。
Nanomedicine (Lond). 2016 Nov;11(21):2861-2876. doi: 10.2217/nnm-2016-0238. Epub 2016 Oct 19.
4
Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders.用于生产固体口服剂型和可吸入干粉的纳米混悬液固化。
Expert Opin Drug Deliv. 2016;13(3):435-50. doi: 10.1517/17425247.2016.1142524. Epub 2016 Feb 3.
5
Theoretical Considerations of the Prigogine-Defay Ratio with Regard to the Glass-Forming Ability of Drugs from Undercooled Melts.关于过冷熔体中药物玻璃形成能力的普里高津-德法伊比率的理论思考。
Mol Pharm. 2016 Jan 4;13(1):241-50. doi: 10.1021/acs.molpharmaceut.5b00688. Epub 2015 Dec 10.
6
Crystallization of Probucol in Nanoparticles Revealed by AFM Analysis in Aqueous Solution.通过水溶液中的原子力显微镜分析揭示普罗布考在纳米颗粒中的结晶
Mol Pharm. 2015 Aug 3;12(8):2972-80. doi: 10.1021/acs.molpharmaceut.5b00236. Epub 2015 Jul 7.
7
Investigation of a nanosuspension stabilized by Soluplus® to improve bioavailability.对由固体分散体辅料(Soluplus®)稳定的纳米混悬剂进行研究以提高生物利用度。
Int J Pharm. 2014 Dec 30;477(1-2):88-95. doi: 10.1016/j.ijpharm.2014.10.025. Epub 2014 Oct 14.
8
Introducing diffusing wave spectroscopy as a process analytical tool for pharmaceutical emulsion manufacturing.介绍扩散波谱法作为药物乳液制造过程分析工具。
J Pharm Sci. 2014 Dec;103(12):3902-3913. doi: 10.1002/jps.24197. Epub 2014 Oct 9.
9
Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions.湿磨诱导萘普生纳米晶混悬液的物理和化学不稳定性。
Int J Pharm. 2014 May 15;466(1-2):223-32. doi: 10.1016/j.ijpharm.2014.03.021. Epub 2014 Mar 11.
10
Biorelevant dissolution of poorly soluble weak acids studied by UV imaging reveals ranges of fractal-like kinetics.通过紫外成像研究的难溶性弱酸的生物相关溶出揭示了类分形动力学范围。
Int J Pharm. 2014 Mar 10;463(1):38-49. doi: 10.1016/j.ijpharm.2013.12.049. Epub 2014 Jan 7.